Profilo
F.
Allan Gordon worked as the Chief Executive Officer at Nile Therapeutics, Inc. and as the Medical Director-Scandinavia at Bristol Myers Squibb Co. He also held the position of Senior Director-Clinical Research at Scios, Inc. and Vice President-Clinical at XOMA Corp.
He was the Senior Vice President-Clinical Development at Resverlogix Corp.
for six years.
Additionally, he worked as an Associate Professor at Karolinska Institutet.
Dr. Gordon earned a doctorate degree from Karolinska Institutet.
Precedenti posizioni note di F. Allan Gordon
Società | Posizione | Fine |
---|---|---|
XOMA CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/08/2017 |
RESVERLOGIX CORP. | Direttore Tecnico/Scientifico/R&S | 01/01/2014 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/2007 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Karolinska Institutet | Corporate Officer/Principal | - |
Formazione di F. Allan Gordon
Karolinska Institutet | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
RESVERLOGIX CORP. | Health Technology |
XOMA CORPORATION | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Aziende private | 2 |
---|---|
Nile Therapeutics, Inc. /Old/ | Health Technology |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
- Borsa valori
- Insiders
- F. Allan Gordon